Atrial Fibrillation and Endothelial Dysfunction: A Potential Link?

Area of Science:

• Cardiology
• Vascular Biology
• Internal Medicine

Background:

• Atrial fibrillation (AF) is the most prevalent cardiac arrhythmia, while coronary atherosclerosis is a leading cause of mortality globally.
• Endothelial dysfunction represents the earliest detectable stage of atherosclerosis.
• Current AF treatments have limitations, potentially due to an incomplete understanding of its complex pathophysiology.

Purpose of the Study:

• To explore mechanistic links between endothelial dysfunction and AF.
• To investigate a novel vascular perspective on AF pathophysiology.
• To highlight evidence associating endothelial dysfunction, AF, and stroke, and discuss potential common therapies.

Main Methods:

• Review of existing research on AF pathophysiology and endothelial dysfunction.
• Analysis of mechanistic links including inflammation, oxidative stress, ischemia, genetics, shear stress, and FGF-23.
• Synthesis of evidence linking systemic vascular endothelial dysfunction with AF and stroke.

Main Results:

• Shared risk factors for AF and atherosclerosis, such as inflammation and oxidative stress, impact both conditions.
• Endothelial dysfunction may represent a key link in the pathophysiology of AF.
• Evidence supports a connection between systemic vascular endothelial dysfunction, AF, and stroke risk.

Conclusions:

• Understanding the vascular dimension of AF pathophysiology is crucial.
• Targeting shared risk factors and endothelial dysfunction may offer a unified therapeutic approach for AF, atherosclerosis, and stroke prevention.
• Further research into common mechanistic pathways is warranted.